Literature DB >> 22073563

[Epidemiology of COPD in Japan].

Yoshiaki Minakata1, Masakazu Ichinose.   

Abstract

The prevalence of COPD in Japan is revealed to be 8.6 % which is almost the same as foreign countries. However, there are many undiagnosed COPD patients. More than half of undiagnosed COPD patients go regularly to medical institution with other diseases. Among the patients who are 40 or more and go clinics with non-respiratory diseases, the prevalence of COPD is 8.6 to 10.3 %. If they have smoking history or some respiratory symptoms, the prevalence of COPD is 22 %. In Japanese reports, atherosclerosis is detected in 73.8 % of COPD patients, and the prevalence of COPD is high in heart failure, ischemic heart failure and liver diseases. The effort to decrease the mortality of COPD in Japan is necessary.

Entities:  

Mesh:

Year:  2011        PMID: 22073563

Source DB:  PubMed          Journal:  Nihon Rinsho        ISSN: 0047-1852


  5 in total

1.  Effects of transdermal tulobuterol on dyspnea and respiratory function during exercise in patients with chronic obstructive pulmonary disease.

Authors:  Masako Ichikawa; Yuzo Kodama; Kaku Yoshimi; Satomi Shiota; Masaki Kotajima; Mami Nakajyo; Kuniaki Seyama; Yoshinosuke Fukuchi; Kazuhisa Takahashi
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

2.  Relationship between pulmonary function and elevated glycated hemoglobin levels in health checkups: A cross-sectional observational study in Japanese participants.

Authors:  Saigo Baba; Toru Takashima; Miki Hirota; Michihiro Kawashima; Etsuo Horikawa
Journal:  J Epidemiol       Date:  2017-01-27       Impact factor: 3.211

3.  COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan.

Authors:  Ataru Igarashi; Yoshinosuke Fukuchi; Kazuto Hirata; Masakazu Ichinose; Atsushi Nagai; Masaharu Nishimura; Hajime Yoshisue; Kenichi Ohara; Jean-Bernard Gruenberger
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-28

4.  The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective.

Authors:  Kartik Deshmukh; Arjun Khanna
Journal:  Tuberc Respir Dis (Seoul)       Date:  2021-02-17

5.  Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance.

Authors:  Chihiro Kato; Hajime Yoshisue; Noriko Nakamura; Takayoshi Sasajima
Journal:  Intern Med       Date:  2021-09-04       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.